ARV

HIV prevention researchers to compare common ARV as a pill and vaginal gel in unique study

PITTSBURGH, July 9 , 2008 In battle with an epidemic that has outpaced nearly all efforts to contain it, researchers are turning to strategies centered on the same antiretroviral (ARV) drugs that have been used successfully to treat HIV in hopes they will be as effective a stronghold for prevent...

Triple ARV Prophylaxis Reduces Viral Load in Breast Milk

A combination of AZT, lamivudine, and nevirapine (AZT/3TC/NVP) taken from week 28 of pregnancy and up to one month after delivery resulted in significantly reduced HIV levels in breast milk// as compared to the HIV levels found in the breast milk of women who were not treated prophylactically. ...

President Clinton and Mylan Chairman and CEO Robert J. Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug-Resistant HIV in Developing Countries

...done an extraordinary job developing a world-class arv franchise in only a few years. Our efforts will co...ed today will create a more convenient second-line arv treatment option. Patients will take three pills o...HO has identified the development of a second-line arv therapy including Atazanavir and Ritonavir as a to...

96-Week Safety and Efficacy Findings Presented for INTELENCE(TM) (etravirine) As Part of HIV Combination Therapy

...dence of viral replication and HIV-1 strains resistant to a NNRTI and other arv agents. This indication is based on Week 24 analyses from two rand... Immune reconstitution syndrome has been reported in patients treated with arv therapy, including INTELENCE. Use in Specific Populations ...

New HIV Study Shows That Large Numbers of Women and People of Color Can Be Successfully Enrolled In U.S. HIV Clinical Studies

...on and/or accumulation of body fat have been observed in patients receiving arv therapy. The causal relationship, mechanism, and long-term consequences of ... Immune reconstitution syndrome has been reported in patients treated with arv therapy. Resistance / Cross Resistance : The potential for HIV cross...

Shifting Scientific, Health Priorities and Global Economic Downturn Impact Investment in HIV Prevention R&D

...tributes to the development of HIV prevention research in a number of ways through pharmaceutical company support. A number of companies have provided arv compounds for development as potential microbicides, and as oral PrEP, along with technical support to microbicide product developers. "The...

Marijuana rivals mainstream drugs for HIV/AIDS symptoms

... income adequacy, having an AIDS diagnosis, taking arv medications, or years on arv medications. But the two groups did differ in that...na were less likely to comply with their regime of arv medications. But perhaps counter-intuitively of th...

Programs to Prevent HIV in Newborns Failing in the Developing World - Over 900 Avoidable HIV Infections Every Day

... In Cambodia, 88 percent of HIV-positive mothers receive no arv prophylaxis at all; Shortages of ARVs and health workers plus poor...ith support from donors, should increase mothers' access to the triple-dose arv regimen, currently provided to only eight percent of those treated to preve...

Victory! Colombian Government Cuts Price of Abbott's Lifesaving AIDS Drug Kaletra 55%, Says AHF

... Colombia is unable to provide antiretroviral therapy to those who need it. UNAIDS estimates that 33,000 people with AIDS who need arv therapy now (62% of the total) are not currently accessing it.(4) Colombia's government is spending $70 million each year for AIDS drugs (all nationa...

Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR for First Generic, Heat-Stable Version of HIV Protease Inhibitor

...rity countries with high AIDS prevalence rates. Matrix's wide range of arv products includes active pharmaceutical ingredients (API) and first- and se...oximately 30% of HIV/AIDS patients in developing countries depend on Matrix arv products. Mylan Inc., which provides products to customers in more tha...

More>>

ARV in Medical Technology

New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine (TDF/FTC) Versus Boosted Protease Inhibitor Regimen of Atazanavir/Ritonavir Plus TDF/FTC Revealed

...body fat may occur in patients receiving antiretroviral therapy. Immune reconstitution syndrome has been reported in patients treated with combination arv therapy. Please see full Prescribing Information, including boxed WARNING, for VIRAMUNE at www.VIRAMUNE.com . Boehringer I...

New PRO2000 HIV-Prevention Findings Important Milestone on Path Toward Development of Effective Vaginal Microbicide

...thers are now testing a new generation of microbicide candidates that contain highly potent antiretrovirals (ARVs) that specifically target HIV. These arv microbicides are based on the same antiretroviral drugs being used successfully in HIV treatment and to prevent mother-to-child transmission of HIV. T...

Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults

...on and/or accumulation of body fat have been observed in patients receiving arv therapy. The causal relationship, mechanism, and long-term consequences of ... Immune reconstitution syndrome has been reported in patients treated with arv therapy. The potential for HIV cross-resistance among protease inhibitors...

New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy

...dence of viral replication and HIV-1 strains resistant to a NNRTI and other arv agents. This indication is based on Week 24 analyses from two randomized,...mune reconstitution syndrome has been reported in patients treated with arv therapy, including INTELENCE -- INTELENCE should be used with caution in ...

Newly Approved HIV Drug Shows Great Promise

...tion in antiretroviral treatment- experienced adult patients, who have evidence of viral replication and HIV-1 strains resistant to an NNRTI and other arv agents. This indication is based on Week 24 analyses from two randomized, double-blind, placebo-controlled trials of Intelence. Both studies were cond...

Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration

...on and/or accumulation of body fat have been observed in patients receiving arv therapy. The causal relationship, mechanism, and long-term consequences of ... Immune reconstitution syndrome has been reported in patients treated with arv therapy. The potential for HIV cross-resistance among protease inhibitors...

Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients

...ever, headache, vomiting, diarrhea, abdominal pain, and myalgia. Immune reconstitution syndrome has been reported in patients treated with combination arv therapy. Please see full Prescribing Information, including boxed WARNING, for VIRAMUNE at http://www.VIRAMUNE.com . About Boehringer Ingelheim ...

New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target

...orkers is a major impediment to drug access; while arv stock-outs are rare, other important drugs are oft...ment. -- In Nigeria, despite a rapid scale up of arv treatment and a free treatment policy, treatment s...gnostic testing access is limited. -- In Russia, arv stock-outs are a severe and ongoing problem. -- ...

Hopkins Report: Focusing on Family Planning Lessens HIV Impact

...ildren orphaned by AIDS. To prevent pregnancy, women with HIV can safely use most contraceptive methods, with just a few exceptions. Even women using arv therapy can choose any method available. Fears about the IUD have proved too broad. According to the latest guidance from the World Health Organizatio...

New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy

...on and/or accumulation of body fat have been observed in patients receiving arv therapy. The causal relationship, mechanism, and long-term consequences of ... Immune reconstitution syndrome has been reported in patients treated with arv therapy. The potential for HIV-cross-resistance among protease inhibitors ...

More>>